The table below shows INTEGRA LIFESCIENCES HOLDINGS CORP's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$9.80M
-$11.26M
$15.76M
$26.16M
$44.34M
$69.08M
Capital expenditure
$14.85M
$28.92M
$15.46M
$13.70M
$9.32M
$6.67M
Investing cash flow
-$14.85M
-$35.92M
-$53.97M
-$13.70M
-$14.07M
-$117.57M
Dividends paid
-
-
-
-
IART operating cash flow (10-K history)
INTEGRA LIFESCIENCES HOLDINGS CORP reported operating cash flow of $50.38M for fiscal year 2025. That is down 61.1% from $129.38M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $116.41M (FY 2016) to $50.38M. Figures come from the company's audited annual reports as filed with the SEC.